Assura (LON:AGR) Stock Price Passes Above 200 Day Moving Average – What’s Next?

Assura Plc (LON:AGRGet Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 48.45 and traded as high as GBX 48.50. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares trading hands.

Analysts Set New Price Targets

AGR has been the topic of a number of analyst reports. Peel Hunt reiterated a “buy” rating and issued a GBX 60 target price on shares of Assura in a research report on Tuesday, September 30th. Shore Capital reiterated a “hold” rating on shares of Assura in a report on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Assura presently has an average rating of “Moderate Buy” and a consensus price target of GBX 60.

Read Our Latest Report on Assura

Assura Price Performance

The company’s fifty day simple moving average is GBX 47.47 and its 200 day simple moving average is GBX 48.45. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05. The firm has a market capitalization of £1.54 billion, a PE ratio of 895.85, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37.

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Featured Stories

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.